# Arcus Biosciences, Inc. (RCUS): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Arcus Biosciences, Inc. (RCUS) is 8/100, ranked against 24,000+ stocks in 35 markets (Quality 14, Value 24, Momentum 41, each scored against its sector).

- StockRank: 8/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 14, Value 24, Momentum 41: each a 0-100 percentile within Healthcare.
- Position: #24,300 overall, #2,358 in Healthcare.
- Listing: United States, NYQ; Healthcare / Biotechnology.
- Last close: 17.76 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 3.3M.

Source: https://moatmap.ai/stock/RCUS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker